← FDA WARNING LETTERS
FDA WARNING LETTER25 August 2026
R3 Medical Companies — FDA Warning Letter
Unapproved New Drugs/Unlicensed Biological Product Violations
What this record is not
Warning-letter details are published by the U.S. FDA; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA. The authoritative text is on fda.gov.
Company
R3 Medical Companies
Letter date
25 August 2026
Issuing office
Center for Biologics Evaluation and Research (CBER)
READ THE FULL LETTER
The complete warning letter, including every cited observation, is published by the FDA. SPEQ surfaces and indexes it for reference — the authoritative text lives on fda.gov.
View on fda.gov →